Pharmacodynamic Effects of Cangrelor in ACS or CCS Patients Undergoing PCI (POMPEII Registry)

NCT04790032 · clinicaltrials.gov ↗

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Percutaneous Coronary Intervention

Interventions

DRUG: Cangrelor

Sponsor

Federico II University